-
Founded in:
1989-01-19 -
Country:
China -
Address:
No. 6, Sanye East Road, Longhua District, Haikou City, Hainan Province -
Tax NO.:
914600002012496387 -
Registered Funds:
10 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sultacillin tosylate |
A new type of oral antibiotic resistant to β-lactamase, synthesized by esterification of sulbactam and ampicillin. The enzyme inhibition of sulbactam can protect ampicillin from the destruction of β-lactamase secreted by resistant bacteria, thereby improving the antibacterial activity of ampicillin. The drug efficacy is 4-8 times stronger than that of ampicillin. It is effective against infections caused by ampicillin-resistant bacteria.
More
A new type of oral antibiotic resistant to β-lactamase, synthesized by esterification of sulbactam and ampicillin. The enzyme inhibition of sulbactam can protect ampicillin from the destruction of β-lactamase secreted by resistant bacteria, thereby improving the antibacterial activity of ampicillin. The drug efficacy is 4-8 times stronger than that of ampicillin. It is effective against infections caused by ampicillin-resistant bacteria. |
0 | ||
| Ampicillin |
The bactericidal ingredient acts on the active reproduction stage of bacteria and has a bactericidal effect by inhibiting the synthesis of bacterial cell wall mucopeptides.
More
The bactericidal ingredient acts on the active reproduction stage of bacteria and has a bactericidal effect by inhibiting the synthesis of bacterial cell wall mucopeptides. |
69-53-4 | 26 | |
| Sulbactam pivoxil |
Competitive irreversible β-lactamase inhibitor, used in combination with ampicillin, synergistic with its antibacterial effect.
More
Competitive irreversible β-lactamase inhibitor, used in combination with ampicillin, synergistic with its antibacterial effect. |
69388-79-0 | 9 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sultacillin tosylate |
A new oral antibiotic resistant to beta-lactamase. Sulbactam's enzyme inhibition can protect ampicillin from the destruction of beta-lactamase secreted by resistant bacteria, thereby improving the antibacterial activity of ampicillin and making it an acid-resistant and enzyme-resistant high-efficiency antibiotic. The efficacy is 4-8 times stronger than ampicillin. It is effective against infections caused by ampicillin-resistant bacteria.
More
A new oral antibiotic resistant to beta-lactamase. Sulbactam's enzyme inhibition can protect ampicillin from the destruction of beta-lactamase secreted by resistant bacteria, thereby improving the antibacterial activity of ampicillin and making it an acid-resistant and enzyme-resistant high-efficiency antibiotic. The efficacy is 4-8 times stronger than ampicillin. It is effective against infections caused by ampicillin-resistant bacteria. |
0 | ||
| Ampicillin |
The bactericidal ingredient acts on the active reproduction stage of bacteria and has a bactericidal effect by inhibiting the synthesis of bacterial cell wall mucopeptides.
More
The bactericidal ingredient acts on the active reproduction stage of bacteria and has a bactericidal effect by inhibiting the synthesis of bacterial cell wall mucopeptides. |
69-53-4 | 26 | |
| Sulbactam pivoxil |
Competitive irreversible B-lactamase inhibitor, used in combination with ampicillin, synergistic with its antibacterial effect.
More
Competitive irreversible B-lactamase inhibitor, used in combination with ampicillin, synergistic with its antibacterial effect. |
69388-79-0 | 9 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cetirizine dihydrochloride |
Selective histamine H1 receptor antagonist, no obvious anticholinergic and anti-5-hydroxytryptamine effect, not easy to pass the blood-cerebrospinal fluid barrier, clinical use of central nervous system inhibitory effect is relatively mild
More
Selective histamine H1 receptor antagonist, no obvious anticholinergic and anti-5-hydroxytryptamine effect, not easy to pass the blood-cerebrospinal fluid barrier, clinical use of central nervous system inhibitory effect is relatively mild |
83881-52-1 | 54 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefaclor |
Antibacterial drug. The beta-lactamase produced by Staphylococcus aureus is relatively stable, so it has a strong antibacterial effect on Gram-positive bacteria; the beta-lactamase produced by Gram-negative bacteria is unstable, so it has a weaker effect on Gram-negative bacteria, and is ineffective against Pseudomonas aeruginosa and anaerobic bacteria.
More
Antibacterial drug. The beta-lactamase produced by Staphylococcus aureus is relatively stable, so it has a strong antibacterial effect on Gram-positive bacteria; the beta-lactamase produced by Gram-negative bacteria is unstable, so it has a weaker effect on Gram-negative bacteria, and is ineffective against Pseudomonas aeruginosa and anaerobic bacteria. |
53994-73-3 | 29 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Rosae Laevigatae Fructus |
|
0 | ||
| SEMEN ALLII TUBEROSI |
|
0 | ||
| Anise oil |
|
8007-70-3 | 10 | |
| Semen Plantaginis |
|
0 | ||
| lycii Fructus |
|
0 | ||
| Cuscutae Semen |
|
0 | ||
| RUBI FRUCTUS |
|
0 | ||
| Morinda officinalis sky white matrix sample |
|
0 | ||
| Phellodendri Chinensis Cortex |
|
0 | ||
| ANEMARRHENAE RHIZOMA |
|
0 | ||
| ASIAN GINSENG |
|
0 | ||
| Angelicae Sinensis Radix |
|
0 |